Steve Kent is currently Non-Executive Chairman at Phlexglobal, 4ways and Pharmaspectra, as well as Non-Executive Director at Imagen Therapeutics. During Steve’s time as an executive, he transformed and quickly grew two very different private equity backed businesses into companies that achieved a main listing on the London Stock Exchange. He was also on the operating Board of a large NASDAQ quoted company. In this podcast, Steve discusses the possible implications of Covid-19 on the biopharmaceutical and wider pharmaceutical markets.

Listen to the Podcast below: